Print Page   |   Sign In   |   Join
RFA Bayer/NASPAG Young Investigator Grant
Share |

Bayer/ NASPAG Young Investigator Grant for Levonorgestrel-Releasing Intrauterine System Long-Acting Reversible Contraception Research - Supported by Bayer HealthCare Pharmaceuticals and sponsored by the North American Society for Pediatric and Adolescent Gynecology.  

 

Please read these instructions carefully.Applications that do not follow these instructions with regards to type size, length, format, and supporting documentation will be rejected.If the application deadline has not passed, the application may be resubmitted after deficiencies are addressed. No extension of the deadline will be granted to allow resubmission in this cycle.

 

Before submitting your application, please be sure of the following items:

 

·         Information Page is included as the first page of the application packet and is fully completed

·         Signed Statement of Conditions is included

·         All requested documents are included

·         Application documents are in 12-point font, single-spaced with 1-inch page margins

 

The entire packet should be submitted as one PDF using this link no later than 11:59PM, EST on November 2, 2018.

 

GENERAL INFORMATION

 

Deadline for receipt of application                 November 2, 2018

Notification of award                                      December 3, 2018

Funding awarded                                           December 15, 2018

Final Report due to NASPAG                        December 15, 2019

 

INTRODUCTION

The North American Society for Pediatric and Adolescent Gynecology (NASPAG) has partnered with the Bayer HealthCare Pharmaceuticals to award funds for one U.S.-based training award to support the development of expertise in Hormonal Intrauterine System Long-Acting Reversible Contraception (LARC) research in adolescent populations. The methods of interest for this funding opportunity are levonorgestrel-releasing intrauterine systems.

The goals of the Bayer/NASPAG Young Investigator Grant are: 1) to promote knowledge of research-based LARC use in adolescent populations, 2) to advance clinical care for adolescent patients desiring LARC, and 3) to facilitate the academic growth, advanced education, and development of future adolescent LARC practitioners and researchers and thereby invest in enhancing the specialty of pediatric and adolescent gynecology care and research. Bayer/ NASPAG Young Investigator Grant for Levonorgestrel-Releasing Intrauterine System Long-Acting Reversible Contraception Research will offer 1-2 grant of $2000-4000 each for research support for ongoing research studies that would benefit from additional funding.

This award is intended to support the academic advancement of adolescent gynecology clinicians from diverse backgrounds (i.e., general OB/GYN, pediatric gynecology, adolescent medicine, reproductive endocrinology, pediatrics, pediatric endocrinology, family medicine, or internal medicine) who are still in early stages of training (i.e., residents, fellows, and faculty in their first 5 years post training) to further an ongoing research project. At the time of application and for the duration of funding, the eligible candidate must be based in programs and institutions in the United States.

PURPOSE OF THE AWARD

The Bayer/NASPAG Young Investigator Award is intended to provide an opportunity for formal exposure to and experience in adolescent contraceptive research and to prepare the applicant for further research experience. The applicant should be intimately involved in the conception, planning, conduct, and reporting of the research. At the end of the award year, the Awardee(s) should have a firm foundation in the fundamentals that will prepare the applicant(s) to begin to conduct independent studies, effectively disseminate findings, and compete successfully for additional funding.

APPLICANT ELIGIBILITY

The Applicant may be: a resident in an ACGME-approved residency training program with intention to pursue a career related to adolescent reproductive health; a fellow in a fellowship program related to adolescent reproductive health (e.g. pediatric and adolescent gynecology, adolescent medicine, reproductive endocrinology, pediatric endocrinology,); a faculty member in the first 5 years of appointment engaged in adolescent reproductive health and gynecologic care.  The focus of this training award is on clinicians, i.e., those who are providing direct care to adolescents. Eligible candidates must be based in programs and institutions in the United States. Candidates cannot have had previous or simultaneous funding from the National Institutes of Health (NIH) or other research funding sources (that is larger than $10,000). Eligible candidates may not have a training award (e.g., NIH T32 or K-award).

Applicants must either be NASPAG members or have a membership application pending (not paid by the award). Awardee(s) are required to submit an abstract related to this research to the 2020 NASPAG ACRM.

AWARD APPLICATION

Applicants must submit the following information:

·         Completed Information Sheet

·         Signed Statement of Conditions

·         Candidate statement

·         The original study proposal

·         Study IRB approval letter—must have IRB approval, not just “in progress”

·         Description of the current status and progress of the study and use of any prior funding (<1 page)

·         Current project needs and budget request and justification (<1 page)

·         Applicant’s current curriculum vitae (in NIH biosketch format)

AWARD ADMINISTRATION AND SELECTION PROCESS

The NASPAG Research Committee will evaluate applications and administer the award(s). Applications will be judged on the scientific merit of the project and the adequacy of additional funding of the proposed budget to meet the scientific objectives.

FUNDING PRIORITIES

Proposals should entail research related to the use of Mirena,® Skyla,® or Kyleena® levonorgestrel-releasing intrauterine systems in adolescents. Potential topic areas include, but are not limited to:

·         Quality of life measures among adolescent users of IUDs

·         Behavioral interventions for compliance, continuation, or management of side effects

·         Acceptability and bleeding profiles of IUDs in distinct adolescent populations

·         Use of social networks (Facebook-Twitter-LinkedIn) to deliver interventions in adolescent health care settings

·         Integration of IUD services in primary care or medical home settings

·         Integration or augmentation of electronic health records to include provider prompts or patient material regarding IUDs

·         IUDs in vulnerable adolescent populations or medically complicated adolescents

·         Screening and management of HIV/Hepatitis/STD infections in adolescent patients with IUDs

·         Regional variations of IUD uptake in adolescent health settings

·         Development of curricula for teaching IUD counseling and placement for practitioners caring for adolescents

·         Other projects of direct relevance to adolescent use of levonorgestrel IUDs

 

TERMS OF THE AWARD

Duration

Award period is one year.

Extension of Award Period

In unusual circumstances, arrangements can be made for an extension of an award. Such a request must be made by the Awardee at least 60 days before the expiration date of the award. This request must be made in writing, specify reasons for requesting the extension, and state a new expiration date. Project extensions of greater than six months will not be considered.

Change of Status of Designated Awardee

If the named Awardee changes affiliations and ceases research in the field for which the award was made, the award will terminate and the remaining balance will be returned to NASPAG.

Location of work

Awards are for investigations in the United States at an accredited medical school, medical center, or institution affiliated with a university teaching program. The Awardee will make all arrangements for conduct of the proposed research projects.

Liability of the North American Society for Pediatric and Adolescent Gynecology and Bayer Healthcare Pharmaceuticals

NASPAG and Bayer assume no financial liability if patient care responsibilities of any kind are undertaken by the Awardee. The Awardee and affiliated institution(s) acknowledge that NASPAG and Bayer are not legally liable for the conduct of the Bayer/NASPAG Young Investigator Award Awardee and associated investigators.

Patent Policy

The Awardee(s) and their respective institution(s) acknowledge that if a patentable invention or discovery is conceived, or conceived and reduced to practice by the Bayer/NASPAG Young Investigator Award during the term of the award year, Bayer and NASPAG must be apprised of the invention and the institution’s plans for protecting such invention under existing institutional patent policy. The Bayer/NASPAG Award program will defer to institutional policies where they are in compliance with those of the Federal government. The Bayer/NASPAG Award program reserves the right where the institution has no patent policy, or policies not in compliance with those of the federal government, to claim rights and interests in the invention or discovery consistent with FAR Clause 52.227-11, Patent Rights-Ownership by the Contractor.

Limitations on Awardee

Awards are made with the stipulation they are to be used only as support for the named Bayer/NASPAG Young Investigator Awardee. Cost for project completion, publications, travel, secretarial support, etc., must be borne by the program/institution and the funding sources identified.  

SUPPORT FACILITIES

The Applicant must submit letters of support if the proposed project uses facilities not routinely available to or directly under the supervision of the sponsoring program.

 

PUBLICATIONS

All discoveries resulting from work supported in part by the Bayer/NASPAG Young Investigator award should be made available to the public and scientific community through approved scientific channels such as national meetings and peer reviewed publications. Publications will acknowledge the support of the Bayer/NASPAG Young Investigator Award. Two reprints of each publication should be forwarded to NASPAG and to Bayer.

 

PROGRESS REPORTS AND MONEY MANAGEMENT

The Awardee(s) is required to submit a final report to NASPAG by December 15, 2019.  NASPAG will maintain the copyright of all such reports. This final report must include an accounting report using Generally Accepted Accounting Procedures showing the distribution of funds with a signature from an institutional official (e.g., accountant, grants manager, administrator from the Office of Sponsored Research). Failure to provide the report may negatively impact the ability of the Awardee(s) and institution(s) to apply for future awards.

 

POST-AWARDEE SURVEYS

The Awardee(s) will be surveyed periodically (once a year) following completion of the award year regarding career paths, subsequent grants/contracts obtained, and publications. The Awardee(s) will be expected to respond to these surveys, as NASPAG will rely on such information to support continuation of such training awards.

Association Management Software Powered by YourMembership  ::  Legal